Immunovant, Inc. (IMVT)
Immunovant, Inc. (IMVT) has reported earnings 27 times since Dec 20, 2019. The stock moves an average of ±8.21% the day after reporting, closing higher 48.1% of the time. Its largest post-earnings gain was +35.16% (May 20, 2026) and its largest decline was -37.99% (Jun 01, 2021). The next earnings report is predicted for 2026-08-07 (estimated).
Earnings reactions
How IMVT moved on each past earnings report.
Earnings Impact
Total Earnings
27
Avg Abs. Movement
±8.21%
Positive %
48.1%
Negative %
51.9%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| May 20, 2026 | ☀ PRE | +35.16% | open_in_new |
| Feb 06, 2026 | ☀ PRE | +12.43% | open_in_new |
| Nov 10, 2025 | ☀ PRE | +0.09% | open_in_new |
| Aug 11, 2025 | ☀ PRE | -4.53% | open_in_new |
Earnings Count
27
Total earnings in dataset
Avg Abs. Movement
±8.21%
Avg % price change on earnings
Institutional ownership
Holdings as of Mar 31, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| ARS | 20260722 | open_in_new SEC.gov |
| DEF 14A | 20260722 | open_in_new SEC.gov |
| DEFA14A | 20260722 | open_in_new SEC.gov |
| 4 | 20260710 | open_in_new SEC.gov |
| 4 | 20260710 | open_in_new SEC.gov |
| 4 | 20260710 | open_in_new SEC.gov |
| 4 | 20260706 | open_in_new SEC.gov |
| 4 | 20260626 | open_in_new SEC.gov |
| 144 | 20260626 | open_in_new SEC.gov |
| 144 | 20260626 | open_in_new SEC.gov |
Frequently asked about IMVT earnings
When does Immunovant, Inc. report earnings next? expand_more
Immunovant, Inc. (IMVT)'s next earnings date is estimated for 2026-08-07. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does IMVT stock move after earnings? expand_more
Over 27 reports, IMVT has moved an average of ±8.21% the session after earnings, closing higher 48.1% of the time.
What was IMVT's biggest post-earnings move? expand_more
IMVT's largest post-earnings gain on record was +35.16% on May 20, 2026, and its largest decline was -37.99% on Jun 01, 2021.
Where can I find Immunovant, Inc.'s SEC filings? expand_more
All of Immunovant, Inc.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right
Reporting around the same time
- ALAMO GROUP INC (ALG) earnings 2026-08-04
- Aligos Therapeutics, Inc. Common Stock (ALGS) earnings 2026-08-05
- AbCellera Biologics Inc. Common Shares (ABCL) earnings 2026-08-05
- Airbnb (ABNB) earnings 2026-08-05
- Arcosa, Inc. (ACA) earnings 2026-08-04
- ACADIA PHARMACEUTICALS INC (ACAD) earnings 2026-08-05
- ACCO BRANDS Corp (ACCO) earnings 2026-08-04
- ProFrac Holding Corp. (ACDC) earnings 2026-08-07